BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11425449)

  • 21. High incidence of a second BCR-ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears.
    Cabot GP; Bentz M; Scholl C; Moos M; Fischer K; Lichter P; Döhner H
    Cancer Genet Cytogenet; 1996 Apr; 87(2):107-11. PubMed ID: 8625254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia.
    Kobzev Y; Domracheva E; Zakharova A; Khoroshko N; Turkina A; Dewald G
    Cancer Genet Cytogenet; 1998 Oct; 106(2):128-34. PubMed ID: 9797777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia.
    Costa D; Espinet B; Queralt R; Carrió A; Solé F; Colomer D; Cervantes F; Hernández JA; Besses C; Campo E
    Cancer Genet Cytogenet; 2003 Mar; 141(2):114-9. PubMed ID: 12606128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH).
    Mancini M; Nanni M; Sirleto P; De Cuia MR; Castoldi GL; Cilloni D; Cimino G; Mecucci C; Pane F; Annino L; Di Raimondo F; Santoro A; Specchia G; Tedeschi A; Todeschini G; Foá R;
    Hematol J; 2001; 2(1):54-60. PubMed ID: 11920234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.
    Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Philadelphia-negative chronic myeloid leukaemia: detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22.
    Nacheva E; Holloway T; Brown K; Bloxham D; Green AR
    Br J Haematol; 1994 Jun; 87(2):409-12. PubMed ID: 7947289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence in situ hybridization for the BCR/ABL rearrangement is dependent on the percentage of nonlymphocytic cells in peripheral blood stem cell harvests.
    Bornhäuser M; Mohr B; Ehrenlechner U; Neubauer A; Ehninger G
    J Hematother; 1998 Oct; 7(5):425-30. PubMed ID: 9829316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Langenhuijsen MM; Ossenkoppele GJ
    Leukemia; 1997 Feb; 11(2):301-5. PubMed ID: 9009097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Philadelphia chromosome in chronic myelogenous leukemia: confirmation of cytogenetic diagnosis in Ph positive and negative cases by fluorescence in situ hybridization.
    Acar H; Stewart J; Connor MJ
    Cancer Genet Cytogenet; 1997 Apr; 94(2):75-8. PubMed ID: 9109930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization.
    Tkachuk DC; Westbrook CA; Andreeff M; Donlon TA; Cleary ML; Suryanarayan K; Homge M; Redner A; Gray J; Pinkel D
    Science; 1990 Oct; 250(4980):559-62. PubMed ID: 2237408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
    Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia.
    Grand FH; Chase A; Iqbal S; Nguyen DX; Lewis JL; Marley SB; Davidson RJ; Goldman JM; Gordon MY
    Genes Chromosomes Cancer; 1998 Oct; 23(2):109-15. PubMed ID: 9739013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insertion (22;9)(q11;q34q21) in a patient with chronic myeloid leukemia characterized by fluorescence in situ hybridization.
    Martín-Subero JI; Lahortiga I; Gómez E; Ferreira C; Larrayoz MJ; Odero MD; García-Delgado M; Novo FJ; Giraldo P; Calasanz MJ
    Cancer Genet Cytogenet; 2001 Mar; 125(2):167-70. PubMed ID: 11369063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of fluorescence in situ hybridization for detecting the bcr/abl gene fusion in interphase cells of routine bone marrow specimens.
    Werner M; Ewig M; Nasarek A; Wilkens L; von Wasielewski R; Tchinda J; Nolte M
    Diagn Mol Pathol; 1997 Oct; 6(5):282-7. PubMed ID: 9458387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.